Cargando…
Natural Compound Library Screening Identifies New Molecules for the Treatment of Cardiac Fibrosis and Diastolic Dysfunction
BACKGROUND: Myocardial fibrosis is a hallmark of cardiac remodeling and functionally involved in heart failure development, a leading cause of deaths worldwide. Clinically, no therapeutic strategy is available that specifically attenuates maladaptive responses of cardiac fibroblasts, the effector ce...
Ejemplares similares
-
cIMP: Synthesis, effector activation, inactivation and occurrence in biological systems
por: Seifert, Roland, et al.
Publicado: (2015) -
Predicting butyrate- and propionate-forming bacteria of gut microbiota from sequencing data
por: Kircher, Berenike, et al.
Publicado: (2022) -
Establishment, Validation, and Initial Application of a Sensitive LC-MS/MS Assay for Quantification of the Naturally Occurring Isomers Itaconate, Mesaconate, and Citraconate
por: Winterhoff, Moritz, et al.
Publicado: (2021) -
Long Noncoding RNA-Enriched Vesicles Secreted by Hypoxic Cardiomyocytes Drive Cardiac Fibrosis
por: Kenneweg, Franziska, et al.
Publicado: (2019) -
Pharmacokinetic Studies of Antisense Oligonucleotides Using MALDI-TOF Mass Spectrometry
por: Herkt, Markus, et al.
Publicado: (2020)